INFUSERS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INFUSERS
Largest movements
- Cash +€23,286
up €23,286 (+44.4%), from €52,450 to €75,736
mainly Trade debts (+€31,362) and Deferred charges and accrued income (+€762)
- Stocks and contracts +€4,611
up €4,611 (+27.2%), from €16,925 to €21,535
- Trade debts +€31,362
up €31,362 (+34.8%), from €90,221 to €121,584
- Tax, wage and social debts -€3,038
down €3,038 (-17.9%), from €16,947 to €13,909
- Gross operating margin -€4,092
down €4,092 (-77.0%), from €5,315 to €1,224
- Financial income +€596
up €596 (+78.1%), from €763 to €1,359
- Taxes -€491
down €491 (-29.5%), from €1,668 to €1,177
- Other operating charges +€159
up €159 (+6.7%), from €2,380 to €2,540
- Financial charges -€91
down €91 (-40.2%), from €226 to €135
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €150,108 | €177,759 | +€27,650 | +18.4% |
| Fixed assets | 21/28 | €960 | €960 | = | 0.0% |
| Financial fixed assets | 28 | €960 | €960 | = | 0.0% |
| Current assets | 29/58 | €149,148 | €176,799 | +€27,650 | +18.5% |
| Stocks and contracts in progress | 3 | €16,925 | €21,535 | +€4,611 | +27.2% |
| Stocks | 30/36 | €16,925 | €21,535 | +€4,611 | +27.2% |
| Amounts receivable within one year | 40/41 | €78,890 | €79,406 | +€516 | +0.7% |
| Trade receivables | 40 | €78,890 | €78,583 | -€307 | -0.4% |
| Other amounts receivable | 41 | - | €823 | +€823 | |
| Cash at bank and in hand | 54/58 | €52,450 | €75,736 | +€23,286 | +44.4% |
| Deferred charges and accrued income | 490/1 | €884 | €122 | -€762 | -86.2% |
| Total equity and liabilities | 10/49 | €150,108 | €177,759 | +€27,650 | +18.4% |
| Equity | 10/15 | €42,098 | €42,266 | +€168 | +0.4% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €35,750 | €35,750 | = | 0.0% |
| Distributable reserves | 133 | €35,750 | €35,750 | = | 0.0% |
| Profit (loss) carried forward | 14 | €148 | €316 | +€168 | +113.3% |
| Amounts payable | 17/49 | €108,010 | €135,493 | +€27,482 | +25.4% |
| Amounts payable within one year | 42/48 | €108,010 | €135,493 | +€27,482 | +25.4% |
| Trade debts | 44 | €90,221 | €121,584 | +€31,362 | +34.8% |
| Suppliers | 440/4 | €90,221 | €121,584 | +€31,362 | +34.8% |
| Advances received on contracts in progress | 46 | €842 | - | -€842 | |
| Taxes, remuneration and social security | 45 | €16,947 | €13,909 | -€3,038 | -17.9% |
| Taxes | 450/3 | €16,947 | €13,909 | -€3,038 | -17.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€1,392 | -€1,437 | -€45 | -3.2% |
| Other operating charges | 640/8 | €2,380 | €2,540 | +€159 | +6.7% |
| Gross operating margin | 9900 | €5,315 | €1,224 | -€4,092 | -77.0% |
| Operating profit (loss) | 9901 | €4,327 | €121 | -€4,206 | -97.2% |
| Financial income | 75/76B | €763 | €1,359 | +€596 | +78.1% |
| Recurring financial income | 75 | €763 | €1,359 | +€596 | +78.1% |
| Financial charges | 65/66B | €226 | €135 | -€91 | -40.2% |
| Recurring financial charges | 65 | €226 | €135 | -€91 | -40.2% |
| Profit (loss) for the period before taxes | 9903 | €4,865 | €1,345 | -€3,520 | -72.4% |
| Income taxes | 67/77 | €1,668 | €1,177 | -€491 | -29.5% |
| Profit (loss) for the period | 9904 | €3,196 | €168 | -€3,028 | -94.7% |
| Profit (loss) for the period to be appropriated | 9905 | €3,196 | €168 | -€3,028 | -94.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.